Antitubercular drugs: new drugs designed by molecular modifications
نویسندگان
1 Glocal School of Pharmacy, Glocal University, Mirzapur Pole, Saharanpur, Uttar Pradesh, India
2 Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al‒Qura University, Makkah, 21955, Saudi Arabia
doi
10.22034/ajgc.2022.4.4چکیده
Tuberculosis is a long-term infection caused by the bacteria Mycobacterium tuberculosis. Long-term TB treatment has several drawbacks, including medication resistance, noncompliance with therapy, and a scarcity of therapeutic options. It is critical to find new medications that are both safer and more effective. Molecular modification is a valuable method for identifying novel chemicals that can overcome these obstacles. The primary tactics to obtain a novel anti-tubercular medication are summarized in this paper.
